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Abstract 
Purpose: To design and synthesize a series of new structural motifs of urease inhibitors, 3-
[{(substituted phenyl) amino} methyl]-5-(3, 4, 5-trimethoxyphenyl)-1,3,4-oxadiazole-2(3H)-thiones and 3-
{[(pyridin-2-yl)amino]methyl}-5-(3,4,5-trimethoxy phenyl)-1,3,4-oxadiazole-2(3H)-thiones from 1, 3, 4-
oxadiazole-2-thione.  
Methods: Targeted Mannich base derivatives were synthesized by the reaction of 1, 3, 4-oxadiazole-2-
thione with formaldehyde and respective aromatic amines. These structural motifs were subjected to 
1H–NMR, 13C–NMR and mass spectrometric analysis. Compound 4, i.e., 1,3,4-oxadiazole-2-thione and 
its corresponding Mannich bases (5-17) were subjected to in silico screening as urease inhibitors, using 
crystal structure of urease (Protein Data Bank ID: 5FSE) as a model enzyme. Furthermore, the targeted 
compounds were evaluated for their in vitro urease inhibition and anti-oxidant activities using thiourea 
and propyl gallate as standards, respectively. 
Results: The docking score of targeted compounds predicted that they are promising urease inhibitors. 
Subsequently, in vitro studies on Jack bean urease supported the results from virtual screening, and 
found compounds 4, 5, 9,10,12, 13, 14 and 15 very potent urease inhibitors with half-maximal inhibitory 
concentration (IC50) values in the range of 5.93 ± 0.13 to 9.76 ± 0.11, relative to thiourea (IC50 = 21.25 ± 
0.15). Compounds 4 – 6, and compounds 12 - 17 also exhibited higher antioxidant activities than propyl 
gallate.  
Conclusion: In view of their potent urease inhibition and antioxidant activities, these structural motifs 
have potentials as new candidates for the development of anti-ulcer drugs.  
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 Compounds derived from 1,3,4-oxadiazole-2-
thione have received  attention as new structural 
motifs for the design and development of novel 
drugs [1]. Compounds with 1,3,4-oxadiazole-2-
thiones cores have occupied a specific place in 
medicinal and synthetic chemistry  because of 
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their extensive range of biological activities such 
as antibacterial [2], antifungal, anti-inflammatory, 
antiviral, anticancer [1], enzyme inhibitor [3], 
anticonvulsant and anti-diabetic properties [4]. 
The 1,3,4-oxadiazole nucleus undergoes a 
variety of chemical reactions such as 
electrophilic and nucleophilic substitutions, as 
well as photochemical and thermal reactions [5]. 
These properties make it a desirable medicinal 
backbone which can be used to construct 
biologically-useful molecules. A number of 1, 3, 
4-oxadiazole-2-thione derivatives are used in 
clinical medicine as antiviral, anticancer, 
antihypertensive and antibiotic agents. These 
include Raltegravir®, Zibotentan®, Tiodazosin, 
Nesapidel and Furamizole [2]. Urea is hydrolyzed 
to ammonia and carbon dioxide in  the presence 
of urease (urea amidohydrolase) [6,7]. The 
ammonia produced as by-product shows 
pathogenic-like behavior in animals and humans, 
leading to hepatic coma, peptic ulcer, hepatic 
encephalopathy, pyelonephritis and encrustation 
in the urinary tract [8]. Helicobacter pylori is an 
acid-sensitive, gram-negative bacterium which 
survives only in the pH range of 7-8. This acid-
sensitive bacterium is able to thrive in the low pH 
environment of the stomach with the help of 
urease, which is produced in a highly active form 
and increases the pH of human stomach through 
the hydrolysis of urea [9]. 
 
Urease is  a virulent factor for H. pylori and 
contributes to mucosal damage in the stomach, 
gastro-duodenal infection, peptic ulcers and 
gastric cancer [10]. Thus, the inhibition of urease 
has attracted much attention as potential strategy 
for designing novel drugs against ulcer. More 
effective and more potent compounds with a 
whole new level of safety and specificity are still 
desired [11]. In this regard, high throughput 
virtual and in vitro biological assay of molecules 
to understand their molecular behaviour in 
specific environments, will aid the identification of 
potent molecules from a crude cocktail [12]. 
Recently, 1,3,4-oxadiazole-2-thiones derivatives 
have been investigated as active jack bean 
urease inhibitors with promising anti-urease 
activities [13]. The aim of the current study was 
to synthesize Mannich bases derived from 1, 3, 
4-oxadiazole-2-thione bearing 3, 4, 5-trimethoxy 
moiety and examine them as potential urease 






Chemicals and reagents used for the synthesis 
of target compounds were purchased from 
Sigma Aldrich and Merck (Lahore, Pakistan). The 
purity of the synthesized structures and progress 
of the reactions were monitored using pre-coated 
silica gel 60 F254 aluminium TLC plates (Merck). 
Their melting points were measured with 
Gallenkamp apparatus, while IR spectra were 
obtained on Bio-Red Merlin or Bruker. The 1H - 
NMR of each synthesized compound was 
recorded at a frequency 300 MHz on Bruker AM 
300 or at a frequency of 500 MHz on Agilent 
Technologies spectrophotometer using CDCl3 or 
DMSO-d6 as solvent. The J values of the 
analyzed compounds are presented in Hertz 
(Hz). The spectra of 13C - NMR were recorded at 
a frequency of 75.5 MHz or 125 MHz. EIMS 
spectra were obtained using Agilent TOF-6220 
analyzer, while the elements were analyzed on a 
Perkin Elmer 2400 CHN instrument. 
 
Synthesis of structural motifs 
 
The strategy for the synthesis of compounds 2 – 
17 is summarized in Scheme 1. Compound 1 (3, 
4, 5-trimethoxybenzoic acid) was transformed 
into ethyl-3, 4, 5-trimethoxybenzoate 2 by 
refluxing in Ethanol for 10 h under anhydrous 
conditions and catalytic amount of concentrated 
H2SO4. The ethyl ester 2 was further converted 
into 3, 4, 5-trimethoxybenzoicacid hydrazide 3 by 
heating with 80 % hydrazine in ethanol solvent 
for 5 h under reflux. The synthesized hydrazide 3 
underwent intermolecular cyclization to yield 5-
(3, 4, 5-trimethoxy phenyl)-1, 3, 4-oxadiazole-2-
thione 4 with carbon disulphide in alkaline 
medium, followed by acidification with dilute 
hydrochloric acid. Compound 4 (1,3,4-
oxadiazole-2-thione) was reacted with 
formaldehyde and substituted anilines and amino 
pyridines to convert it into the respective 






Synthesis of 3-[{(substituted phenyl or 
pyridin-2-yl) amino} methyl]-5-(3,4,5-
trimethoxyphenyl)-1,3,4-oxadiazole-2(3H)-
thiones (5 – 17)  
 
Formalin (37 %, 0.002 moles) and 0.002 moles 
of relevant amine were reacted with 0.002 moles 
5-(3, 4, 5-trimethoxyphenyl)-1, 3, 4-oxadizole-2-
thiones in ethanol (about 40 ml), and vortexed for 
1 – 6 h at 30 °C.  The progress of the reaction 
was monitored by TLC, and at the end, the 
mixture was cooled overnight. Thereafter, the 
resultant sediments were recovered by filtration, 
rinsed in an appropriate solvent and subjected to 
re-crystallisation in alcohol. 
 
Akram et al 




Scheme 1: Synthesis of Mannich Bases derived 
from 1, 3, 4-oxadiazole-2-thiones. 
 
Compounds 5 – 17 were identified through IR 
spectroscopy by broad bands in the range 
3387 – 3410 cm-1 which is unique to –NH 
group. Peaks were seen between 1615 to 
1665 cm-1 obviously from stretches in C=N, 
and also between 1145 to1225 cm-1 because 
of C=S stretches. Product formation was 
depicted in 1H - NMR spectroscopy by NH 
proton peak between 5.4 and 5.9 ppm and a 
–CH2 peak close to 5.4 ppm.  
 
For compounds 6 – 7 and 15 – 17, the –NH 
proton peak appeared near 8.4 ppm (when 
electron withdrawing group i.e. NO2 was 
attached to phenyl ring at ortho position with 
respect to –NH proton). The CH2 and NH 
protons coupled with each other to give rise 
to doublet and triplet (J = 6.8-7.5 Hz) 
respectively. Product formation was 
confirmed by the appearance of amino 
methyl signals, since amino methylene is 
formed at the last stage of the reaction. 
Aromatic phenyl protons appeared at 6.45 – 
8.16 ppm and de-shielded by the ring current 
effect. Protons from the OCH3 group 
resonated between 3. 81 and 3.95 ppm, 
whereas methyl protons were found between 
2.38 and 2.51 ppm up the field. In 13C - NMR 
analysis, CH2 peak at 57.6 – 58.4-ppm 
confirmed the amino methyl function. 
 
However, this was absent in the reactant 4. 
These results were strengthened by DEPT 
spectra which showed different peaks (same 
or opposite sides of the solvent signal) for 
different types of carbons. Two significant 
peaks observed at 176 and 159 ppm due to 
carbon linkage with sulphur and nitrogen 
atoms, respectively. The signals of all carbon 
atoms of the aromatic ring were observed in 
region 101 – 153 ppm downfield. The carbon 
atoms of methyl and methoxy groups 
attached to aromatic ring appeared at 17.08 
– 21.29 ppm and 56.46 – 61.14 respectively. 
Unambiguous confirmation of the structure 
(4) was obtained by X-ray crystallographic 
analysis [14].  
 
Urease assay and assessment of 
inhibition 
 
Compounds 4 – 17 were screened for ability to 
inhibit urease in vitro by the phenol hypochlorite 
method described by Weatherburn [15]. In 96-
well plate, 25 μl jack bean urease enzyme 
solution was incubated with reaction mixture 
containing 55 μl of phosphate buffer, 5 μl of test 
compound followed by 15 μl of 100 mM urea at 
37°C for 15 min. For colour appearance, 100 μl 
of phenol-hypochlorite reagent was added in 
each well followed by incubation at 37°C for 30 
min. The results were evaluated by calculating 
change in absorbance taken by 96 wells plate 
reader at 620 nm and by using formula 100 – 
[(OD of test / OD of control) × 100. The entire 
assay was performed in triplicate at pH 7 and 
using thiourea as standard inhibitor of urease. 
  
Determination of antioxidant activity 
 
DPPH scavenging activity was measured using a 





The interactions of 1,3,4-oxadiazole-2-thione 
derivatives with urease were studied theoretically 
through docking experiments, which were 
performed using AutoDockTools version 1.5.6 
(ADT) software [18]. Default ten docking runs 
were set for all compounds to observe their 
interactions with active site of urease molecule. 
Ligand and receptor binding energy/affinity were 
calculated with ADT software package by using 
search parameter Genetic Algorithm. Ligand 
structure was optimized using Avogadro software 
[19]. 
 
Sporosarcina pasteurii (formerly Bacillus 
pasteurii) urease (SPU) [20] file with PDB code: 
5FSE (contain three protein chains designated 
as A, B, and C) was downloaded in PDB format 
from RCSB Protein Data Bank, which was 
further processed for docking studies by 
isolating chain-C which play vital role in urease 
activity and contain active pockets [21]. Chain-A 
and chain-B along with non-protein fragments 
e.g. ligand and solvent molecules were 
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removed using BIOVIA Discovery Studio 
Visualizer v16.1.0.15350. 
 
Docking analysis was done using ADT. 
Hydrogens were added and non-polar hydrogen 
were merged in receptor molecule (5FSE chain-
C). Moreover, the Kollman charges were also 
added to the receptor molecule. For docking, the 
receptor macromolecule was considered as a 
rigid structure. AutoGrid program was used for 
generating 58 × 60 × 70 Å grid points and 0.254 
Å spacing for affinity (grid) maps, while ADT 
default parameter and functions, along with all 
possible torsions of the ligand molecule were 
used in the electrostatic, bonding and energy 
calculations. Lamarckian genetic algorithm (LGA 
4.2) was used for docking simulations. Ten 
different binding conformations of ligand with 
receptor were obtained with their respective 
binding energies/affinities. The pose with 
strongest binding affinity to receptor (out of the 
ten) was chosen as the most stable one and 
further employed in the post-docking analysis. 
 
Statistical analysis  
 
Biological studies were performed at five different 
concentrations in order to calculate IC50 values 
using linear regression method with Graphpad 
Prism 5. The results are shown as mean ± SEM 








The reaction time was 2.5 h, resulting in a yield 
of 81 %. The product was a light yellow solid; 
melting point = 206 – 208 °C. IR (cm-1); 3398 
(NH), 2938 (Ar-CH, aromatic), 2831 (CH2, 
aliphatic), 1622 (C = N, oxadiazole), 1602, 1581 
(C = C, aromatic), 1508 (NO2), 1209, 1149, (C-O-
C), 1142 (C= S). 1H - NMR(CDCI3, 500 MHz,  
ppm); 8.25 (d, 1H, Ar-H J = 2 Hz), 7.71 (dd, 1H, 
Ar-H, J = 7.5 Hz, 2 Hz), 7.35 (s, 2H, Ar-H), 7.29 
(d, 1H, J = 8 Hz), 5.73 (d, 2H, CH2, J = 7.5 Hz), 
5.44 (t, 1NH, J = 7.5 Hz), 4.02 (s, 6H, OCH3), 
3.92(s, 3H, OCH3), 2.38 (s, 3H, CH3). 13C - NMR 
(CDCl3, 125 MHz,  ppm); 176.51 (C = S), 
159.36 (C = N), 153.91 (2C), 147.78, 143.32, 
142.85, 131.01, 130.97, 117.03, 114.68, 106.75, 
103.79 (2C) 61.14 (1C, OCH3), 58.23 (1C, CH2), 
56.54 (2C, OCH3), 17.80 (1C, CH3). HRMS (Esi): 
m /z calculated for C19H20N4O6S (M + Na)+: 
455.0996; found: 455.1001. Analytically 
calculated for C19H20N4O6S: C = 52.77; H = 4.66; 




2(3H)-thione (6)  
 
The reaction time was 5.4 h, resulting in a yield 
of 69 %, The product was a yellow solid; melting 
point = 178 – 180 °C, IR(cm-1); 3406 (NH), 2945 
(Ar-CH, aromatic), 2869 (CH2, aliphatic), 1629 (C 
= N, oxadiazole),1602, 1553 (C = C, aromatic), 
1184 (C= S), 1166, 1141 (C-O-C). 1H - 
NMR(CDCI3, 500 MHz,  ppm); 8.75 (t, 1NH, J = 
7.5 Hz) 8.20 (d, 1H, J = 2.5 Hz), 7.50 (s, 2H, Ar-
H), 7.15 – 7.11 (m, 2H, Ar-H), 5.66 (d, 2H, CH2, J 
= 7.5 Hz), 3.91 (s, 9H, OCH3). 13C - NMR (CDCl3, 
125MHz, ppm); 176.47 (C = S), 159.21 (C = N), 
153.77 (2C), 142.08, 140.71, 136.56, 133.56, 
126.21, 123.53, 116.77, 116.73, 103.87 (2C),, 
61.07 (1C, OCH3), 58.21 (1C, CH2), 56.46 (2C, 
OCH3). EI, m/z (Irel, %): 475 [M + Na]+ (35), 402.2 
(38),455.2 (12), 455.2 (15), 291.0 (100), 
269.1(25), 229.1 (20), 195.1 (15). Analitically 
calculated for C18H17ClN4O6S: C = 47.74; H = 







The reaction time was 3 h, resulting in a yield of 
79 %; The product was a yellow solid; melting 
point = 210 – 212 °C, IR (cm-1); 3402 (NH), 2912 
(Ar-CH, aromatic), 2864 (CH2, aliphatic), 1615 (C 
= N, oxadiazole), 1640, 1582 (C = C) aromatic 
skeleton) 1506 (NO2), 1207 (C= S) 1202, 1126, 
(C-O-C). 1H - NMR(DMSO – d6,  500 MHz,  
ppm); 8.70 (t, NH, J = 6.8 Hz), 7.93 (d, 1H, Ar-H, 
J = 2 Hz), 7.46 (dd, 1H, Ar-H, J = 8 Hz, 2 Hz), 
7.34 (s, 2H, Ar-H), 7.18 (d, 1H, Ar-H, J = 8 Hz), 
5.72 (d, 2H, CH2 , J = 7 Hz), 3.88 (s, 6H, OCH3), 
3.85 (s, 3H, OCH3), 2.51 (s, 3H, CH3). 13C - NMR 
(DMSO – d6, 125 MHz,  ppm); 175.55 (C = S), 
158.92 (C = N), 153.39 (2C), 141.05, 140.09, 
137.64, 132.66, 127.25, 125.52, 116.84, 115.37, 
103.54 (2C), 60.18 (1C, OCH3), 56.74 (1C, CH2), 
56.13 (2C, OCH3), 19.31 (1C, CH3). HRMS (Esi): 
m /z calculated for C19H20N4O6S (M + Na)+: 
455.0996; found: 455.1003. Analitically 
calculated for C19H20N4O6S: C = 52.77; H = 4.66; 
N = 12.96; found: C = 52.95; H = 4.59; N = 
12.68. 
 
The detailed synthesis and spectroscopic and 
spectrometric data of compounds 8 – 17 are 
provided in supplementary material. 
 
Docking analysis data 
 
Docking scores (Table 1) i.e. kinase inhibition 
values (KI), binding energy and interactions of 
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the synthesized compounds 4 – 17 in active 
pocket of receptor urease enzyme (PDB ID: 
5FSE Chain-C) predicted these compounds as 
promising urease inhibitors, which was further 
supported by the experimental results (Table 2). 
In docking studies, it was observed that 
compound 5 (Figure 1 – 2) and 13 form hydrogen 
bond  with HIS323 (Table 3) which is next to 
CYS322 blocked by quinone known as urease 
inhibitor [21]. 
 
Urease inhibition  
 
The virtual screening of compounds 4 – 17 as 
promising urease inhibitors was further 
supported by their in vitro urease inhibition 
against Jack bean urease in an assay using 
standard inhibitor thiourea, in which thiourea had 
an IC50 value of 21.25 ± 0.15 μM. Almost all the 
synthesized derivatives (twelve out of fourteen) 
of this series exhibited remarkable urease 
inhibitory potency superior to that of thiourea 
(Table 2). The interaction of compound 5 
(representative) with the active site of urease is 
depicted in Figure 1, while the active site groups 





Figure 1: Ligand 5 represented with stick structure 
inside the active site of urease (PDB code: 5FSE) 
depicted in MMS form [22]. 
 
 
Figure 2: Hydrogen bonding (represented by dotted 
line) and interacting sites of urease (PDB code: 5FSE 
Chain-C) with ligand 5 represented by structure 
contain magenta colour stick[18] 
 
Table 2: Inhibitory activities of 1, 3, 4-oxadiazole 
derivatives 4 – 17 against Jack bean urease 
 
Compound  % Inhibition at 
0.25 mM 
IC50 (µM) 
4 97.73±0.17 5.93±0.13 
5 97.18±0.21 6.35±0.15 
6 45.63±0.12 - 
7 92.64±0.23 27.64±0.17 
8 97.14±0.18 12.43±0.14 
9 97.27±0.24 8.54±0.17 
10 97.83±0.15 9.76±0.11 
11 96.12±0.17 15.23±0.12 
12 97.15±0.19 9.15±0.16 
13 97.46±0.15 6.38±0.12 
14 97.86±0.19 9.24±0.13 
15 97.13±0.22 7.36±0.15 
16 97.34±0.15 16.2±0.11 
17 97.25±0.19 15.82±0.13 




The DPPH radical scavenging activity is a 
standard assay in antioxidant activity 
measurements. In the current study, the standard 
antioxidant compounds propyl gallate and 
quercetin were used as positive controls for 
comparison with the tested compounds. The 
antioxidant activities of the synthesized 
compounds are shown in Table 4. 
 
Table 4: Antioxidant activity of 1, 3, 4-oxadiazoles 
derivatives 4 – 17 by DPPH radical scavenging method 
 
Compound Antioxidant activity 
% Inhibition at 0.5 
mM 
IC50 (µM) 
4 87.24±0.21 37.63±0.15 
5 85.54±0.23 41.27±0.17 
6 85.79±0.18 42.53±0.13 
7 17.19±0.14 - 
8 38.29±0.17 - 
9 42.39±0.15 - 
10 16.53±0.15 - 
11 86.87±0.23 52.42±0.18 
12 86.42±0.21 42.54±0.17 
13 86.51±0.19 42.16±0.15 
14 86.14±0.23 43.28±0.18 
15 87.38±0.22 32.42±0.18 
16 88.29±0.18 44.93±0.15 
17 86.21±0.19 35.15±0.15 
Quercetin 85.65±0.15 12.24±0.12 




In silico studies showed that all the ligands 
interact with active site and have ability to occupy 
it like quinone. Predicted hydrogen bonding 
(Table 3) also forecast that these molecules have 
ability to inhibit urease activity permanently by 
bonding to the active site, as depicted by 
representative molecule 5. 
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Table 1: Docking scores of compounds 4 – 17 with receptor molecule (PDB code: 5FSE) calculated through ADT 
[18] 
 










4 297.43 -4.45 546.34 -6.31 -0.63 1.19 
5 425.08 -4.71 355.57 -7.09 -0.97 2.39 
6 461.68 -4.6 426.72 -6.98 -1.61 2.39 
7 528.13 -4.41 590.29 -6.79 -1.58 2.39 
8 481.14 -4.17 880.27 -6.85 -1.6 -2.68 
9 500.66 -4.79 308.28 -7.47 -1.47      2.68 
10 378.61 -5.55 85.76 -7.64 -1.17 2.09 
11 426.80 -4.51 497.39 -6.89 -1.22 2.39 
12 279.12 -5.57 82.39 -7.66 -1.09 2.09 
13 300.62 -5.56 83.55 -7.95 -1.15 2.39 
14 290.75 -5.63 74.5 -7.72 -1.05 2.09 
15 160.26 -5.24 144.9 -7.62 -0.99 2.39 
16 361.67 -5.32 125.36 -7.71 -1.44 2.39 
17 121.20 -4.43 569.55 -6.51 -0.99 2.09 
 
Table 3: Receptor molecule (PDB code: 5FSE Chain-C) active site interactions with compounds 4 – 17 as 




Groups involved in 
hydrogen bonding 
with Ligand 
Active pocket groups involved in interaction with ligand 
4  GLU314, MET318, LEU319, CYS322, ALA366, MET367, GLY368, ARG369 
5 HIS323 GLU314, ASP317, MET318, VAL321, CYS322, HIS323, LEU365, ALA366, MET367, GLY368 
6 HIS323 LYS169, GLU314, ASP317, MET318, LEU319, VAL321, CYS322, HIS323, ALA366, MET367,  
7 GLY368 ASP313, GLU314, ASP317, MET318, VAL321, CYS322, LEU365, ALA366, GLY368 
8  LYS169, GLU314, ASP317, MET318, LEU319, VAL321, CYS322, HIS323, ALA366, MET367 
9 GLY368 GLU314, ASP317, MET318, VAL321, CYS322, LEU365, ALA366,  
10  GLU314, ASP317, MET318, VAL321, CYS322, HIS323, ARG339, LEU365, ALA366, MET367 
11 HIS323 GLU314, ASP317, MET318, LEU319, VAL321, CYS322, HIS323, ARG339, ALA366 
12  LYS169, GLU314, ASP317, MET318, LEU319, VAL321, CYS322, ALA366 
13 HIS323 GLU314, ASP317, MET318, VAL321, CYS322, HIS323, ARG339, ALA366, MET367 
14  GLU314, MET318, VAL321, CYS322, HIS323, LEU365, ALA366, MET367, GLY368 
15  LYS169, GLU314, ASP317, MET318, LEU319, CYS322, HIS323, ALA366, MET367 
16  GLU314, MET318, VAL321, CYS322, LEU365, ALA366, MET367, GLY368 
17  LYS169, GLU314, ASP317, MET318, VAL321,LEU365, ALA366, GLY368, ARG369 
 
The urease inhibition activities of all the 
synthesized compounds ranged in IC50 values 
from 5.93 μM to 27.64 μM. The results indicate 
that 3, 4, 5-trimethoxy-substituted benzene next 
to oxadiazole ring shows excellent urease 
inhibition. Among the investigated compounds, 
compound 4 bearing methoxy groups at 3,4,5 
positions in the benzene ring, was observed as 
the most effective urease inhibitor, with IC50 
value of 5.93 ± 0.13 μM. Compound 5 bearing 
methyl group at position 2, and nitro group at 
position 5 of the benzene ring showed stronger 
inhibitory activity close to 6.35 μM, when 
compared with compound 7 with a methyl group 
at position 4 and nitro group at position 2, which 
was less active.  
 
Compound 9 bearing electron-donating methoxy 
group at p-position and electron-withdrawing 
nitro group at o-position was slightly more active 
(IC50 value of 8.54 ± 0.17 μM) than compounds 8 
and 11 having electron-donating methoxy group 
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at o- and electron-withdrawing nitro group at p- 
positions. Compounds 12, 13 and 14 with fluoro, 
ethyl and ido substitutions, respectively at meta 
position, showed good activity, with IC50 ranging 
from 6.38 ± 0.12 to 9.24 ± 0.13 μM. Compound 
15 bearing trifluoromethyl group at 5 position was 
more active (IC50 value = 7.36 ± 0.15 μM) than 
compound 16 with trifluoromethyl group at 
positions 6 of substituted pyridine ring in the 
parent, 1,3,4-oxadiazole-2-thione core. 
 
The antioxidant activities of the most effective 
compounds ranged from 32.42 ± 0.18 to 45.28 ± 
0.18 μM. The 3, 4, 5-trimethoxy-substituted 
benzene next to oxadiazole ring showed 
excellent antioxidant activity. Compounds 15 and 
17 bearing substituted pyridine ring next to amino 
methyl group in parent 1,3,4-oxadiazole-2-thione 
core exhibited excellent antioxidant activities with 
IC50 values of 32.42 ± 0.18 μM and 35.15 ± 0.15 
 μM, respectively when compared with standard 
propyl gallate (IC50 = 46.32 ± 0.11μM). Similarly, 
compounds 12, 13, and 14 having fluoro, ethyl 
and ido substitutions, respectively at meta 
position in substituted phenyl rings showed good 
antioxidant potencies, with IC50 in the range of 





Thirteen derivatives of 1, 3, 4-oxadiazole-2-
thiones 5 – 17 have been synthesized 
successfully, with good yields, and thereafter 
comprehensively characterized. In silico and in 
vitro data indicate that they are potent urease 
inhibitors. The synthesized compounds also 
display good antioxidant activities. On the basis 
of these findings, these compounds possess 
potentials as candidates for the development of 
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